Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

Trails Edge Capital Partners, LP reported a 9.90% stake in Sensei Biotherapeutics, Inc. (Schedule 13G)

Event Feb 18, 2026 · Filed Feb 25, 2026

Trails Edge Capital Partners, LP reported a 9.90% stake in Sensei Biotherapeutics, Inc., 126,010 shares, as a passive investor on Feb 18, 2026. Filed Feb 25, 2026 (Schedule 13G).

Stake
9.90%
Shares
126,010
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Trails Edge Capital Partners, LP9.90%126,010
Trails Edge Biotechnology Master Fund, LP9.90%126,010
Ortav Yehudai9.90%126,010

Source

View original at SEC

Related